Endometrial Carcinoma May Favor Partial, but Not Complete, Loss of the TGF-β Signaling Pathway

Proceedings of the National Academy of Sciences of the United States of America- United States

doi 10.1073/pnas.1903646116

Full Text

Abstract

Available in

Date

Authors

Publisher

Proceedings of the National Academy of Sciences

Related search

Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma

Trends in Molecular Medicine
Molecular MedicineMolecular Biology
2019English

Analysis of the TGF Β Functional Pathway in Epithelial Ovarian Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2001English

TGF-β Signaling

WormBook
2005English

PIK3CA Amplification Associates With Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

G3BP1 Activates the TGF-β/Smad Signaling Pathway to Promote Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

DHEA-induced Ovarian Hyperfibrosis Is Mediated by TGF-β Signaling Pathway

Journal of Ovarian Research
GynecologyOncologyObstetrics
2018English

LncRNA Np_5318 Promotes Renal Ischemia‑reperfusion Injury Through the TGF‑β/Smad Signaling Pathway

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

TGF-β Signaling and the Development of Osteoarthritis

Bone Research
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2014English

TTRAP Is a Novel Component of the Non-Canonical TRAF6-TAK1 TGF-β Signaling Pathway

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy